Felix Schumacher

Company: Roche

Job title: Program Leader Targeted Therapeutics

Seminars:

Optimizing Architecture of Brain Shuttle-Antisense Oligonucleotide Conjugates for the Treatment of Neurological Disorders in In Vivo Studies 11:30 am

Aspects and conceptual design considerations of brain shuttle-ASO conjugates Analyzing the translational feasibility of this system to revolutionize potentials for clinical systemic targeting of neurological disorders Potential of peripheral administered CNS-targeting ASOsRead more

day: Conference Day One